MARINUS PHARMACEUTICALS, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 66 rows in 2025. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2025-02-11: Reporting owner Ezickson Elan; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-02-11: Reporting owner Ezickson Elan; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-02-11: Reporting owner Ezickson Elan; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2025-02-11: Reporting owner Ezickson Elan; Form 4; Security Stock Option (Right to Buy); Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2025-02-11 | Ezickson Elan Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,450 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Ezickson Elan Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,900 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Ezickson Elan Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,200 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | Ezickson Elan Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,375 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Ezickson Elan Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $12.60 exercise price | 2025-02-11 | |
| 2025-02-11 | Ezickson Elan Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $7.12 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,450 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,900 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,200 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,375 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $12.60 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $8.28 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,750 0 owned after | $15.84 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,750 0 owned after | $24.76 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,625 0 owned after | $4.84 exercise price | 2025-02-11 | |
| 2025-02-11 | Fischer Seth H. Z. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −3,850 0 owned after | $6.92 exercise price | 2025-02-11 | |
| 2025-02-11 | Hulihan Joseph Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,125 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Hulihan Joseph Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −98,250 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Hulihan Joseph Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −115,418 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | Hulihan Joseph Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −77,175 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Hulihan Joseph Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −115,000 0 owned after | $12.60 exercise price | 2025-02-11 | |
| 2025-02-11 | Hulihan Joseph Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −101,250 0 owned after | $8.28 exercise price | 2025-02-11 | |
| 2025-02-11 | Hulihan Joseph Officer (CHIEF MEDICAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −100,000 0 owned after | $4.56 exercise price | 2025-02-11 | |
| 2025-02-11 | Johnson Marvin Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,450 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Johnson Marvin Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,900 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Johnson Marvin Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −32,400 0 owned after | $8.01 exercise price | 2025-02-11 | |
| 2025-02-11 | MANNING MARTHA E Officer (SVP, GEN. COUNSEL & CORP. SEC.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,125 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | MANNING MARTHA E Officer (SVP, GEN. COUNSEL & CORP. SEC.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −98,250 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | MANNING MARTHA E Officer (SVP, GEN. COUNSEL & CORP. SEC.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −74,468 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | MANNING MARTHA E Officer (SVP, GEN. COUNSEL & CORP. SEC.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −57,900 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | MANNING MARTHA E Officer (SVP, GEN. COUNSEL & CORP. SEC.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −57,500 0 owned after | $12.60 exercise price | 2025-02-11 | |
| 2025-02-11 | MANNING MARTHA E Officer (SVP, GEN. COUNSEL & CORP. SEC.) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −75,000 0 owned after | $10.08 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,450 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,900 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,200 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −12,375 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −16,500 0 owned after | $12.60 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,000 0 owned after | $8.28 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,750 0 owned after | $15.84 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,750 0 owned after | $24.76 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −2,625 0 owned after | $4.84 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,925 0 owned after | $6.00 exercise price | 2025-02-11 | |
| 2025-02-11 | MAYLEBEN TIMOTHY M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −1,575 0 owned after | $57.20 exercise price | 2025-02-11 | |
| 2025-02-11 | Pfanstiel Steven Officer (CFO AND COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −57,300 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Pfanstiel Steven Officer (CFO AND COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −114,600 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Pfanstiel Steven Officer (CFO AND COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −126,585 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | Pfanstiel Steven Officer (CFO AND COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −74,475 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Pfanstiel Steven Officer (CFO AND COO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −220,000 0 owned after | $13.99 exercise price | 2025-02-11 | |
| 2025-02-11 | Shafer Christina Officer (CHIEF COMMERCIAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −49,125 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Shafer Christina Officer (CHIEF COMMERCIAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −98,250 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Shafer Christina Officer (CHIEF COMMERCIAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −78,188 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | Shafer Christina Officer (CHIEF COMMERCIAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −57,900 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Shafer Christina Officer (CHIEF COMMERCIAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,000 0 owned after | $12.60 exercise price | 2025-02-11 | |
| 2025-02-11 | Shafer Christina Officer (CHIEF COMMERCIAL OFFICER) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −128,000 0 owned after | $13.71 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −167,825 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −335,650 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −360,000 0 owned after | $5.94 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −193,050 0 owned after | $10.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −290,000 0 owned after | $12.60 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −450,000 0 owned after | $8.28 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −200,000 0 owned after | $4.28 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,917 0 owned after | $15.84 exercise price | 2025-02-11 | |
| 2025-02-11 | Braunstein Scott Director, Officer (CHAIRMAN AND CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,500 0 owned after | $31.76 exercise price | 2025-02-11 | |
| 2025-02-11 | Silverstein Christine Berni Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −10,450 0 owned after | $1.40 exercise price | 2025-02-11 | |
| 2025-02-11 | Silverstein Christine Berni Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −20,900 0 owned after | $9.74 exercise price | 2025-02-11 | |
| 2025-02-11 | Silverstein Christine Berni Director | 4 | Stock Option (Right to Buy) Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −32,400 0 owned after | $5.94 exercise price | 2025-02-11 |